Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Cash from Operations (2022 - 2025)

Envoy Medical's Cash from Operations history spans 4 years, with the latest figure at 5685000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 5685000.0 for Q4 2025, down 11.67% from a year ago — trailing twelve months through Dec 2025 was 18201000.0 (down 1.4% YoY), and the annual figure for FY2025 was 18201000.0, down 1.4%.
  • Cash from Operations for Q4 2025 was 5685000.0 at Envoy Medical, down from 4331000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 1099000.0 in Q3 2023 to a low of 11145000.0 in Q4 2023.
  • The 4-year median for Cash from Operations is 4182500.0 (2023), against an average of 3877875.0.
  • Peak annual rise in Cash from Operations hit 120.92% in 2023, while the deepest fall reached 908.1% in 2023.
  • Year by year, Cash from Operations stood at 2379000.0 in 2022, then tumbled by 368.47% to 11145000.0 in 2023, then surged by 54.32% to 5091000.0 in 2024, then fell by 11.67% to 5685000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 5685000.0, 4331000.0, and 4460000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.